Medication info
Albion Tablets

Albion Tablets

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
This medication is a round, white film-coated tablet.
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201901270 · Approved 2019.02.28

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, take 2 tablets orally twice daily, in the morning and before bedtime, with or without food. 1) Gastric and duodenal ulcers Take 2 tablets twice daily, or 4 tablets once daily before bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and before bedtime. The same dosage applies to ulcers caused by nonsteroidal anti-inflammatory drugs or concomitant use to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks and usually within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily, or 4 tablets once daily before bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson's syndrome

  • Gastric/duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric/duodenal ulcers caused by non-steroidal anti-inflammatory drugs.
View approved original text

This medication is used for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective in conditions with excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It is used to prevent ulcers that may occur post-surgery or gastric/duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). Additionally, it helps prevent Mendelson's syndrome when administered before anesthesia. This medication is used for the treatment and prevention of various gastrointestinal diseases.

How to take

Adult dose

○ Adults Usually, take 2 tablets orally twice daily, in the morning and before bedtime, with or without food. 1) Gastric and duodenal ulcers Take 2 tablets twice daily, or 4 tablets once daily before bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and before bedtime. The same dosage applies to ulcers caused by nonsteroidal anti-inflammatory drugs or concomitant use to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks and usually within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily, or 4 tablets once daily before bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those who have had allergic reactions to this medication or its components. It is also unsafe to administer to patients with a history of acute porphyria, those with poor kidney function, surgical patients, pregnant women or those who may become pregnant, premature infants and newborns, and patients on potassium-restricted diets. Caution is advised when using in patients with impaired liver function, a history of drug allergies, the elderly, patients with kidney issues, and those taking non-steroidal anti-inflammatory drugs concurrently. Particularly, it can conceal symptoms of gastric cancer; thus, in middle-aged or older patients who recently developed or changed indigestion symptoms, confirm that it is not a malignant disease before administering. Patients with helicobacter pylori infection and gastric/duodenal ulcers should undergo bacterial eradication treatment as well. Serious patients in intensive care or those with hypophosphatemia and patients who have difficulty swallowing should be monitored closely. While taking this medication, allergic reactions such as skin rashes, urticaria, angioedema, breathlessness, hypotension may occur, thus if such symptoms arise, immediately discontinue the medication and consult a physician. Rarely, blood tests may show decreased white blood cells or platelets, so if symptoms like fatigue, bleeding, or fever occur, tests should be conducted and medications stopped if necessary. If symptoms of liver dysfunction or jaundice appear, discontinue the medication immediately. There may be irregular heart rhythms, so caution is needed if there are symptoms like dizziness or heart-related issues. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain; stools may darken, but this does not require special treatment. In severe patients or the elderly, neurological issues like confusion, drowsiness, headaches, insomnia, and hallucinations may occur, necessitating careful observation. Muscle pain or joint pain may occur, and in rare cases, serious muscle damage symptoms have been reported; if any abnormal symptoms arise, discontinue the medication. Skin rashes or hair loss may occur infrequently. This medication should not be used for long periods, and if there is no therapeutic effect, it is advisable to switch to another medication. Elderly patients or those with chronic lung disease, diabetes, and immunocompromised conditions may have increased risk for pneumonia, necessitating caution. If dizziness or drowsiness occurs, avoid driving or operating hazardous machinery. This medication may interact with other medications, so if taking other drugs, inform your physician or pharmacist, especially if taking medications that affect blood coagulation, as frequent blood tests may be required. It is safest for pregnant women or those who may become pregnant, and lactating mothers to refrain from using this medication. Safety and efficacy have not been fully established for children, so it is advisable not to use it in this population. In case of overdose, treatments such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may help. This medication can reduce gastric acid secretion, promoting bacterial growth in the stomach, thus regular examinations, including eye tests, may be needed with long-term use.

Side effects

  • anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 60 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelofibrosis
  • aplastic anemia
  • dyskeratosis
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • sensation of heaviness in the head
  • sense of illness
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • myotonic contractions
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • reduced libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. Additionally, it is best to store it at room temperature between 1°C and 30°C. Proper storage helps to maintain the medication's effectiveness.

Appearance and packaging

Appearance

This medication is a round, white film-coated tablet.

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.